Decentralized science funding is the family of mechanisms DeSci uses to route capital to research without a central grant committee: community-weighted matching, pay-for-demonstrated-impact, token-holder-curated grants, and treasuries that fill continuously from token markets rather than episodic fundraising.

Why science funding is being rethought

Traditional grant funding concentrates decisions in a small number of agencies and committees, with long cycles and heavy application overhead. The pressure became acute after the 2025 wave of U.S. federal research-funding cuts: a JAMA Internal Medicine study found that NIH grant terminations disrupted 383 active clinical trials — about 1 in 30 — affecting more than 74,000 enrolled participants. Against that backdrop health-research commentators began treating decentralized funding, governance, and data-sharing as credible alternative infrastructure rather than a Web3 curiosity. Roughly 50 active DeSci initiatives now span funding DAOs, publishing, healthcare data, and IP management.

Quadratic funding

Quadratic funding amplifies a matching pool by the breadth of community support: many small donations attract more matching than one whale donating the same total, because the match scales with the square of the sum of square roots of contributions. Gitcoin made it the default mechanism for open-source and public-goods funding and has run dedicated DeSci rounds distributing community-matched grants to research projects.

Retroactive funding

Retroactive public-goods funding inverts the grant: instead of predicting which proposals will succeed, it rewards work that has already proven valuable — on the theory that it is easier to agree on what was useful than on what will be. The model was popularized by Optimism's Retro Funding rounds, which have distributed hundreds of millions of OP to infrastructure and tooling, and DeSci programs borrow it for reproducibility work and datasets whose value only shows after publication.

Token-curated grants and IP-NFT deal flow

DeSci DAOs put funding decisions to their token holders: proposals are sourced and reviewed (typically by expert working groups), then approved by token vote, with the funded intellectual property tokenized as an IP-NFT held by the DAO — a structure pioneered by Molecule (docs). VitaDAO has deployed $4.7M across 31 research projects this way, and vertical DAOs replicate the model per disease area — HairDAO for hair loss, CryoDAO for cryopreservation research.

Launchpads and curve-funded treasuries

The newest layer skips grant rounds entirely: launchpads such as Bio Protocol curate new bioDAOs and fund them through token launches, so the research treasury fills from an open token market and keeps filling as the token trades — continuous funding priced by the crowd instead of a committee.

How Caper approaches this

Caper is built around that last model. Launching a caper puts a research community's treasury on a bonding curve: anyone can buy in at a price set by the curve, and part of every trade accrues to the caper's own treasury, so funding is continuous rather than a one-shot round. The community then directs the treasury through on-chain proposals — PAYOUT pays a lab, supplier, or researcher directly; INVEST lets one research caper back another. Because members keep a pro-rata exit right at all times, backers are never locked into an agenda they no longer support.